Muscle and Fitness
Oral semaglutide 25 mg launched at $149/month in the US, significantly below the $1,350/month list price for injectable Wegovy
Phase 2 trial data indicate that the most common side effects are gastrointestinal including nausea, vomiting, diarrhoea, and constipation particularly during dose escalation, which is consistent with other GLP-1-containing therapies
Within research environments, this peptide has been examined for its interactions with cellular regulatory mechanisms and molecular signaling processes
Front Immunol (2018) 9:1961
A professor of medicine at Northwestern University's Feinberg School of Medicine, he helped lead the clinical trials that brought semaglutide to market, and he spent the decades before that treating obesity with diet, behavior change, and lifestyle coaching